Kozak & Associates Inc. Cuts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Kozak & Associates Inc. reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the 4th quarter, HoldingsChannel reports. The fund owned 2,008 shares of the healthcare conglomerate’s stock after selling 71 shares during the quarter. UnitedHealth Group accounts for approximately 0.2% of Kozak & Associates Inc.’s investment portfolio, making the stock its 25th biggest holding. Kozak & Associates Inc.’s holdings in UnitedHealth Group were worth $1,030,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of UNH. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group during the third quarter worth $27,000. Global Wealth Strategies & Associates lifted its holdings in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the last quarter. West Financial Advisors LLC acquired a new position in shares of UnitedHealth Group during the third quarter valued at $32,000. RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group during the 3rd quarter valued at about $37,000. Finally, Quarry LP increased its position in UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 37 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.1 %

Shares of UnitedHealth Group stock traded up $0.32 during midday trading on Monday, reaching $513.32. The company had a trading volume of 2,141,610 shares, compared to its average volume of 3,099,270. The firm has a market cap of $472.40 billion, a PE ratio of 33.44, a P/E/G ratio of 1.53 and a beta of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The stock has a fifty day moving average price of $559.83 and a 200 day moving average price of $561.31.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue was up 9.2% on a year-over-year basis. During the same quarter last year, the firm posted $6.56 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.64%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on UNH shares. Bank of America lowered their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Royal Bank of Canada lowered their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Truist Financial reduced their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, December 9th. Three equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $627.58.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.